M. Chmielewski

Immunology · with Abken · 2015

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Chmielewski trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Trinchieri
  2. Christopher A. Hunter

Papers from M. Chmielewski's perspective

Ordered by how strongly the researchers M. Chmielewski trusts endorse each paper. Same corpus, a different order for every researcher.

  1. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (Science Translational Medicine)
  2. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (New England Journal of Medicine)
  3. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. (Molecular Therapy)
  4. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial (The Lancet)
  5. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia (New England Journal of Medicine)
  6. Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. (Blood)
  7. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia (Science Translational Medicine)
  8. IL-23 promotes tumour incidence and growth (Nature)
  9. Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.
  10. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Their papers